News
October 17, 2024
By Asha Bolton
Revolutionary Muscle Health Ingredient PeptiStrong® Transforms the Need to Chase More Protein
New York, NY – October 16th, 2024 – Nuritas, a global leader in health and wellness ingredients, proudly announces the latest data on PeptiStrong®, a groundbreaking natural peptide network ingredient derived from fava beans. This revolutionary advancement in muscle health supports muscle mass maintenance, particularly the loss of response to leucine within protein as we age, and enhances the utilisation of protein, offering a potent alternative to synthetic supplements like Leucine, HMB, and Creatine.
PeptiStrong® stands out as a game-changer in muscle growth and maintenance, particularly for older adults. Latest studies have demonstrated that PeptiStrong® is as effective as Leucine at only 25% of the typical dose, 60% more effective than HMB at half the usual dose, and matches Creatine in ATP synthesis with 5x superior mTOR upregulation. This breakthrough means users can achieve better muscle health outcomes with reduced side effects, lower supplement volumes, and decreased costs.
In laboratory tests conducted in Dublin, Ireland, using C2C12 myotubes, PeptiStrong® showcased its remarkable efficacy. It equalled Leucine’s effectiveness at a quarter dose and surpassed HMB’s efficiency by 60% at half the dose. Moreover, in human myofibroblasts, PeptiStrong® enhanced muscle protein synthesis (MPS) pathway activation by 40% in young cells and 22% in aged cells when combined with low doses of Leucine. When paired with HMB, PeptiStrong® achieved a 130% increase in MPS pathway activation in young cells and a 27% increase in aged cells. Notably, PeptiStrong® outperformed Creatine by five times at a low concentration.
Dr. Andy Franklyn-Miller, Chief Medical Officer at Nuritas, emphasized the significance of these findings: “PeptiStrong® addresses the ‘Leucine trigger’ in older adults, a critical threshold for stimulating muscle protein synthesis. With aging, muscles often develop anabolic resistance, becoming less responsive to added protein. PeptiStrong® offers a promising solution by making better use of available protein and overcoming anabolic resistance, supporting muscle health for all.”
Dr. Nora Khaldi, CEO and Founder of Nuritas, highlighted the broader impact of this innovation: “Maintaining muscle health is crucial for reducing all-cause mortality and improving quality of life. PeptiStrong® provides a novel approach to muscle health, delivering better outcomes with reduced supplement intake through plant-based solutions. Nuritas is pioneering a new paradigm in health ingredients, focusing on overall wellness.”
With PeptiStrong®, Nuritas is set to transform muscle health and wellness, offering a natural, effective alternative to traditional supplements. This innovation promises to enhance the quality of life for millions, particularly older adults, by promoting better muscle health with fewer supplements.
About Nuritas
Nuritas is at the forefront of health and wellness innovation, utilizing artificial intelligence and 8 years of biological raw data technology to discover and develop natural peptide-based ingredients for all health verticals and multiple sectors. Committed to improving health outcomes globally, Nuritas partners with leading organizations to bring revolutionary solutions to market.
1. Owen Connolly, Robert Radford, Niamh Mohan, Nora Khaldi, Andy Franklyn-Miller, and Brian Keogh. The anabolic response of protein supplements is augmented by fava bean hydrolysate.